CareDx (NASDAQ:CDNA) was given a new $18.00 price target on by analysts at Wells Fargo & Company.
CareDx (CDNA): Rethinking Valuation After a Sharp Short-Term Share Price Rebound [Yahoo! Finance]
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
CareDx (NASDAQ:CDNA) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
CareDx (NASDAQ:CDNA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.